The effect of ipratropium nasal spray on bronchial methacholine challenge

Chest

Volumn 128, Issue 3, 2005, Pages 1245-1247

  Reid, John K ^a   Davis, Beth E ^a   Cockcroft, Donald W ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Airway hyperresponsiveness; Ipratropium bromide nasal spray; Methacholine challenge test

Indexed keywords

IPRATROPIUM BROMIDE; METHACHOLINE; NOSE SPRAY; PLACEBO;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; METHACHOLINE CHALLENGE TEST; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

EID: 24944497608     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1245     Document Type: Article

References (17)

1. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Grit Care Med 2000; 161:309-329
2. Juniper EF, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests: tidal breathing method; laboratory procedure and standardization. 2nd ed. Lund, Sweden: Astra Draco AB, 1994
3. Cockcroft DW, Killian DN, Mellon JJ, et al. Protective effects of drugs on histamine induced asthma. Thorax 1977; 32:429-437
4. Crimi N, Palermo F, Oliveri R, et al. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Eur Respir J 1992; 5:560-566
5. Greenspon LW, Morrissey WL. Factors that contribute to inhibition of methacholine-induced bronchoconstriction. Am Rev Respir Dis 1986; 133:735-739
6. Watase T, Okuda M. The effects of autonomotropic drugs on allergic nasal mucosa. Rhinology 1986; 24:181-186
7. Sjogren I, Juhasz J. Ipratropium in the treatment of patients with perennial rhinitis. Allergy 1984; 39:457-461
8. Malmberg H, Grahne B, Holopainen E, et al. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol 1983; 8:273-276
9. Kirkegaard J, Mygind N, Molgaard F, et al. Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol 1987; 79:585-590
10. Meltzer EO. Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol 1992; 90:1055-1064
11. Becker B, Borum S, Nielsen K, et al. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhea in patients with perennial non-allergic rhinitis. Clin Otolaryngol 1997; 22:132-134
12. Sjogren I, Jonsson L, Koling A, et al. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis: a double-blind, cross-over placebo-controlled and randomized dose-response study. Acta Otolaryngol 1988; 106:453-459
13. Baroody FM, Majchel AM, Roecker MM, et al. Ipratropium bromide (atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol 1992; 89:1065-1075
14. Borum S, Becker B, Mygind N, et al. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhea. Rhinology 1996; 34:198-200
15. Wagenmann M, Baroody FM, Jankowski R, et al. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy 1994; 24:288-290
16. Sanwikarja S, Schmitz PI, Dieges PH. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non-allergic rhinitis. Ann Allergy 1986; 56:162-166
17. Naclerio RM, Baroody FM. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol 1992; 90:1051-1054